Literature DB >> 15388493

Relaxin-induced changes in renal sodium excretion in the anesthetized male rat.

Alsadek H Bogzil1, Rachel Eardley, Nick Ashton.   

Abstract

Pregnancy is associated with profound changes in renal hemodynamics and electrolyte handling. Relaxin, a hormone secreted by the corpus luteum, has been shown to induce pregnancy-like increases in renal blood flow and glomerular filtration rate (GFR) and alter osmoregulation in nonpregnant female and male rats. However, its effects on renal electrolyte handling are unknown. Accordingly, the influence of short (2 h)- and long-term (7 day) infusion of relaxin on renal function was determined in the male rat. Short term infusion of recombinant human relaxin (rhRLX) at 4 microg.h(-1).100 g body wt(-1) induced a significant increase in effective renal blood flow (ERBF) within 45 min, which peaked at 2 h of infusion (vehicle, n = 6, 2.1 +/- 0.4 vs. rhRLX, n = 7, 8.1 +/- 1.1 ml.min(-1).100 g body wt(-1), P < 0.01). GFR and urinary excretion of electrolytes were unaffected. After a 7-day infusion of rhRLX at 4 microg/h, ERBF (1.4 +/- 0.2 vs. 2.5 +/- 0.4 ml.min(-1).100 g body wt(-1), P < 0.05), urine flow rate (3.1 +/- 0.3 vs. 4.3 +/- 0.4 microl.min(-1).100 g body wt(-1), P < 0.05) and urinary sodium excretion (0.8 +/- 0.1 vs. 1.2 +/- 0.1 micromol.min(-1).100 g body wt(-1), P < 0.05) were significantly higher; plasma osmolality and sodium concentrations were lower in rhRLX-treated rats. These data show that long-term relaxin infusion induces a natriuresis and diuresis in the male rat. The mechanisms involved are unclear, but they do not involve changes in plasma aldosterone or atrial natriuretic peptide concentrations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388493     DOI: 10.1152/ajpregu.00509.2004

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  13 in total

Review 1.  The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.

Authors:  Jennifer M Sasser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

2.  Sex-specific computational models for blood pressure regulation in the rat.

Authors:  Sameed Ahmed; Anita T Layton
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-10

Review 3.  Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia.

Authors:  Kirk P Conrad
Journal:  Semin Nephrol       Date:  2011-01       Impact factor: 5.299

4.  Relaxin-mediated renal vasodilation in the rat is associated with falls in glomerular blood pressure.

Authors:  Aihua Deng; Kirk Conrad; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-10-18       Impact factor: 3.619

5.  Relaxin Attenuates Organ Fibrosis via an Angiotensin Type 2 Receptor Mechanism in Aged Hypertensive Female Rats.

Authors:  Giannie Barsha; Sarah L Walton; Edmund Kwok; Katrina M Mirabito Colafella; Anita A Pinar; Lucinda M Hilliard Krause; Tracey A Gaspari; Robert E Widdop; Chrishan S Samuel; Kate M Denton
Journal:  Kidney360       Date:  2021-09-10

Review 6.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 7.  G-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and prevention.

Authors:  Kirk P Conrad
Journal:  Hum Reprod Update       Date:  2016-07-06       Impact factor: 15.610

8.  Antidiuretic effects of the endothelin receptor antagonist avosentan.

Authors:  Ovidiu Constantin Baltatu; Radu Iliescu; Christian E Zaugg; Jane F Reckelhoff; Pat Louie; Christoph Schumacher; Luciana Aparecida Campos
Journal:  Front Physiol       Date:  2012-04-18       Impact factor: 4.566

Review 9.  Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection.

Authors:  Javier Díez; Luis M Ruilope
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2015-11-26

10.  Receptor-induced dilatation in the systemic and intrarenal adaptation to pregnancy in rats.

Authors:  Vanessa M Ferreira; Thiago S Gomes; Luciana A Reis; Alice T Ferreira; Clara V Razvickas; Nestor Schor; Mirian A Boim
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.